Xceleron Achieves Significant Growth in 2009 - Raises Funds and Expands Core Capabilities to Fuel Further Growth

GERMANTOWN, Md.--(BUSINESS WIRE)--Xceleron, a leader in providing drug developers with early insights from human data, announced today that it is expanding its bioanalytical capabilities following a year of strong growth.

MORE ON THIS TOPIC